Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Partin

Urology

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Urology|April 11, 2001
Prostate-specific antigen and new serum biomarkers for evaluation of chemopreventive agentsA W Partin, L S Marks
Urology|April 11, 2001
Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasiaW A Sakr, A W Partin
Urology|July 1, 1996
Anatomic approach for placement of surgical drains after radical retropubic prostatectomy: long-term effects on postoperative painT Niesel, A W Partin, P C Walsh
Urology|January 1, 1995
OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostateJ I Epstein, M Carmichael, A W Partin
Urology|April 11, 2001
The role of prostate needle biopsy in evaluation of chemopreventive agentsL S Marks, J I Epstein, A W Partin
Urology|September 8, 1998
An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 casesG D Carlson, C B Calvanese, A W Partin
Urology|September 1, 1995
Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment?D M Quinlan, A W Partin, P C Walsh
Urology|January 14, 1999
Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable diseaseH B Carter, J I Epstein, A W Partin
Urology|January 1, 1996
Ureteral bladder augmentation using the lower pole ureter of a duplicated systemJ Ben-Chaim, A W Partin, R D Jeffs
Urology|June 15, 1999
Adenocarcinoma of the prostate in men younger than 40 years of age: diagnosis and treatment with emphasis on radical prostatectomy findingsK M Ruska, A W Partin, J I Epstein, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Urology|April 11, 2001
Prostate-specific antigen and new serum biomarkers for evaluation of chemopreventive agentsA W Partin, L S Marks
Urology|April 11, 2001
Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasiaW A Sakr, A W Partin
Urology|July 1, 1996
Anatomic approach for placement of surgical drains after radical retropubic prostatectomy: long-term effects on postoperative painT Niesel, A W Partin, P C Walsh
Urology|January 1, 1995
OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostateJ I Epstein, M Carmichael, A W Partin
Urology|April 11, 2001
The role of prostate needle biopsy in evaluation of chemopreventive agentsL S Marks, J I Epstein, A W Partin
Urology|September 8, 1998
An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 casesG D Carlson, C B Calvanese, A W Partin
Urology|September 1, 1995
Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment?D M Quinlan, A W Partin, P C Walsh
Urology|January 14, 1999
Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable diseaseH B Carter, J I Epstein, A W Partin
Urology|January 1, 1996
Ureteral bladder augmentation using the lower pole ureter of a duplicated systemJ Ben-Chaim, A W Partin, R D Jeffs
Urology|June 15, 1999
Adenocarcinoma of the prostate in men younger than 40 years of age: diagnosis and treatment with emphasis on radical prostatectomy findingsK M Ruska, A W Partin, J I Epstein, et al.
Pageof 6